3CEN | pdb_00003cen

Factor XA in complex with the inhibitor N-(2-(((5-chloro-2-pyridinyl) amino)sulfonyl)phenyl)-4-(2-oxo-1(2H)-pyridinyl)benzamide


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.60 Å
  • R-Value Free: 
    0.294 (Depositor), 0.295 (DCC) 
  • R-Value Work: 
    0.249 (Depositor), 0.249 (DCC) 
  • R-Value Observed: 
    0.251 (Depositor) 

wwPDB Validation 3D Report Full Report

Validation slider image for 3CEN

Ligand Structure Quality Assessment 


This is version 1.2 of the entry. See complete history

Literature

Structure-Activity Relationships of Anthranilamide-Based Factor Xa Inhibitors Containing Piperidinone and Pyridinone P4 Moieties

Corte, J.R.Fang, T.Pinto, D.J.P.Han, W.Hu, Z.Jiang, X.-J.Li, Y.-L.Gauuan, J.F.Hadden, M.Orton, D.Rendina, A.R.Luettgen, J.M.Wong, P.C.He, K.Morin, P.Chang, C.-H.Cheney, D.L.Knabb, R.M.Wexler, R.R.Lam, P.Y.S.

(2008) Bioorg Med Chem Lett 18: 2845-2849

  • DOI: https://doi.org/10.1016/j.bmcl.2008.03.092
  • Primary Citation Related Structures: 
    3CEN

  • PubMed Abstract: 

    Introduction of the phenyl piperidinone and phenyl pyridinone P4 moieties in the anthranilamide scaffold led to potent, selective, and orally bioavailable inhibitors of factor Xa. Anthranilamide 28 displayed comparable efficacy to apixaban in the rabbit arteriovenous-shunt (AV) thrombosis model.


  • Organizational Affiliation
    • Bristol-Myers Squibb Research and Development, PO Box 5400, Princeton, NJ 08543, USA. james.corte@bms.com

Macromolecule Content 

  • Total Structure Weight: 32.52 kDa 
  • Atom Count: 2,550 
  • Modeled Residue Count: 286 
  • Deposited Residue Count: 286 
  • Unique protein chains: 2

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
COAGULATION FACTOR X, HEAVY CHAIN234Homo sapiensMutation(s): 0 
EC: 3.4.21.6
UniProt & NIH Common Fund Data Resources
Find proteins for P00742 (Homo sapiens)
Explore P00742 
Go to UniProtKB:  P00742
PHAROS:  P00742
GTEx:  ENSG00000126218 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP00742
Sequence Annotations
Expand
Reference Sequence
Find similar proteins by:|  3D Structure
Entity ID: 2
MoleculeChains  Sequence LengthOrganismDetailsImage
COAGULATION FACTOR X, LIGHT CHAINB [auth L]52Homo sapiensMutation(s): 0 
EC: 3.4.21.6
UniProt & NIH Common Fund Data Resources
Find proteins for P00742 (Homo sapiens)
Explore P00742 
Go to UniProtKB:  P00742
PHAROS:  P00742
GTEx:  ENSG00000126218 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP00742
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
FXA

Query on FXA



Download:Ideal Coordinates CCD File
C [auth A]N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE
C23 H17 Cl N4 O4 S
MIJGLXFQYBTIFY-UHFFFAOYSA-N
Binding Affinity Annotations 
IDSourceBinding Affinity
FXA BindingDB:  3CEN Ki: 5.5 (nM) from 1 assay(s)

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.60 Å
  • R-Value Free:  0.294 (Depositor), 0.295 (DCC) 
  • R-Value Work:  0.249 (Depositor), 0.249 (DCC) 
  • R-Value Observed: 0.251 (Depositor) 
Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 56.9α = 90
b = 72.5β = 90
c = 78.8γ = 90
Software Package:
Software NamePurpose
CNSrefinement
PDB_EXTRACTdata extraction
HKL-2000data reduction
HKL-2000data scaling
CNXrefinement

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

  • Released Date: 2008-05-20 
  • Deposition Author(s): Chang, C.-H.

Revision History  (Full details and data files)

  • Version 1.0: 2008-05-20
    Type: Initial release
  • Version 1.1: 2011-07-13
    Changes: Version format compliance
  • Version 1.2: 2024-10-30
    Changes: Data collection, Database references, Derived calculations, Structure summary